The current valuation score of AstraZeneca PLC is 9.42, ranking 24 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 26.32, which is 157.60% below the recent high of 67.80 and 2.38% above the recent low of 25.69.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.